tirzepatide migraines and Mounjaro: Separating Side Effects from Coincidence Chronic Migraines Treatment in San
Description
If privacy concerns are preventing you from starting treatment at all, an oral option might lower that barrier

Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
You can shift your injection day by one or two days if needed, but try to maintain roughly seven-day intervals to avoid breakthrough hunger or accidental overlap

In this context, an interesting approach to producing MP with enhanced anti-obesogenic activity could be possible using polymers and nanoparticles

There are two incretins, known as glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1), that share many common actions in the pancreas but have distinct actions outside of the pancreas

Weeks 9-12: 7.5mg once weekly (optional)
